Critical Response to Article “Network Pharmacology and Experimental Validation to Explore the Effect and Mechanism of Kanglaite Injection Against Triple-Negative Breast Cancer” [Letter]

Abstract

Frans Dany, Uly Alfi Nikmah, Lisa Andriani Lienggonegoro Center for Biomedical Research, Health Research Organization, National Research and Innovation Agency (BRIN), Cibinong, West Java, IndonesiaCorrespondence: Frans Dany, Center for Biomedical Research, Health Research Organization, National Research and Innovation Agency (BRIN), Genomic Building, Cibinong, Jl. Raya Bogor No. 490, Cibinong, West Java, 16911, Indonesia, Email [email protected]; [email protected]

Keywords

• kanglaite
• triple-negative breast cancer
• network pharmacology
• letter